Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,141 | 11,298 | 13,049 | N/A | N/A |
| Receivables | 4,605 | 10,082 | 18,877 | N/A | N/A |
| Inventories | 11,344 | 19,531 | 21,831 | N/A | N/A |
| TOTAL | $45,571 | $47,341 | $63,868 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 843 | 1,442 | 1,071 | N/A | N/A |
| Other Non-Current Assets | 3,898 | 6,676 | 2,406 | 0 | 0 |
| TOTAL | $4,741 | $8,118 | $3,477 | $N/A | $N/A |
| Total Assets | $50,312 | $55,459 | $67,345 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 177 | 9,821 | 301 | N/A | N/A |
| Accounts payable and accrued liabilities | 8,856 | 7,234 | 27,295 | 0 | 0 |
| Accrued Expenses | 11,436 | 10,265 | 16,381 | N/A | N/A |
| TOTAL | $20,474 | $27,611 | $48,200 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 185 | 362 | 13,209 | N/A | N/A |
| Deferred Revenues | 5 | 291 | 4,223 | N/A | N/A |
| TOTAL | $1,428 | $2,323 | $14,016 | $N/A | $N/A |
| Total Liabilities | $21,902 | $29,934 | $62,216 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37 | 11 | N/A | N/A | N/A |
| Common Shares | 7 | 20 | 15 | N/A | N/A |
| Retained earnings | -196,178 | -166,246 | -143,527 | N/A | N/A |
| TOTAL | $28,410 | $25,525 | $5,129 | $N/A | $N/A |
| Total Liabilities And Equity | $50,312 | $55,459 | $67,345 | $0 | $0 |